LONDON, July 17, 2026 /PRNewswire/ -- Ananda Pharma Limited is a UK-based biopharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions. It has lead programmes in endometriosis and chemotherapy induced peripheral neuropathy (CIPN). The...
Hence then, the article about first patient dosed in chemotherapy induced peripheral neuropathy clinical trial was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( First Patient Dosed in Chemotherapy Induced Peripheral Neuropathy Clinical Trial )
Also on site :
- Descendants: Wicked Wonderland Team Breaks Down The Movie's Mysterious Ending: 'We Shot It A Number Of Different Ways'
- ‘Age of Attraction’ Is Netflix’s Top New Reality Launch, But ‘Star Search’ & ‘Calabasas Confidential’ Struggle
- PVR Inox’s Sanjeev Kumar Bijli On India’s Box Office Recovery, Cinema Expansion & Cannes Acquisitions Haul